Bifogade filer
Interim Report Q3 2022
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Magle Chemoswed via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
2022-11-09 08:29:00
Today, on 9 November 2022, Magle Chemoswed Holding AB (publ) has published its interim report for Q3 2022.
Q3 2022 KEY INDICATORS
- Net sales amounted to 34.1MSEK (32.2)
- EBITDA equalled 4.8 MSEK (4.9)
- Operating profit (EBIT) is 1.4 MSEK (1.9)
- Profit after tax amounted to 1.2 MSEK (1.5)
- Earnings per share SEK 0,1 (0,1) per share
JAN-SEPT 2022 KEY INDICATORS
- Net sales amounted to 99.7 MSEK (96.2)
- EBITDA equalled 18.9 MSEK (12.5)
- Operating profit (EBIT) is 8.9 MSEK (3.8)
- Profit after tax amounted to 7.9 MSEK (3.0)
- Earnings per share SEK 0,7 (0,3) per share
“Magle Group continued to deliver healthy year-on-year growth, both in terms of revenues and operating profit. The EBITDA margin is continuously in line with our financial target of 20%, and we remain well on track to deliver on our long-term strategic goals” says Justin Pierce, CEO of Magle Group.
The full report is available at https://maglegroup.com/financial-reports/